These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35582052)

  • 1. Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report.
    Li PH; Tang Y; Wen HZ
    World J Clin Cases; 2022 Apr; 10(11):3573-3578. PubMed ID: 35582052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
    Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P
    J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical ulcerative colitis treated by herbs-partitioned moxibustion: A case report.
    Lin YY; Zhao JM; Ji YJ; Ma Z; Zheng HD; Huang Y; Cui YH; Lu Y; Wu HG
    World J Clin Cases; 2020 Apr; 8(8):1515-1524. PubMed ID: 32368545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.
    Paoluzi P; D'Albasio G; Pera A; Bianchi Porro G; Paoluzi OA; Pica R; Cottone M; Miglioli M; Prantera C; Sturniolo G; Ardizzone S
    Dig Liver Dis; 2002 Nov; 34(11):787-93. PubMed ID: 12546514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial.
    Gionchetti P; Ardizzone S; Benvenuti ME; Bianchi Porro G; Biasco G; Cesari P; D'albasio G; De Franchis R; Monteleone G; Pallone F; Ranzi T; Trallori G; Valpiani D; Vecchi M; Campieri M
    Aliment Pharmacol Ther; 1999 Mar; 13(3):381-8. PubMed ID: 10102972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis.
    Zhang L; Wu YB; Dai YK; Liu Q; Ren YJ; Xu SJ; Pan HG; Chen WJ; Li RL; Hu L
    PLoS One; 2021; 16(9):e0257599. PubMed ID: 34543327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
    Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
    Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.
    Bokemeyer B; Hommes D; Gill I; Broberg P; Dignass A
    J Crohns Colitis; 2012 May; 6(4):476-82. PubMed ID: 22398060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.
    Meucci G; Fasoli R; Saibeni S; Valpiani D; Gullotta R; Colombo E; D'Incà R; Terpin M; Lombardi G;
    Inflamm Bowel Dis; 2012 Jun; 18(6):1006-10. PubMed ID: 21830282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroduodenitis associated with ulcerative colitis: A case report.
    Yang Y; Li CQ; Chen WJ; Ma ZH; Liu G
    World J Clin Cases; 2020 Sep; 8(17):3847-3852. PubMed ID: 32953863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review and update on ulcerative colitis
    Gajendran M; Loganathan P; Jimenez G; Catinella AP; Ng N; Umapathy C; Ziade N; Hashash JG
    Dis Mon; 2019 Dec; 65(12):100851. PubMed ID: 30837080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).
    Fellermann K; Schiefke I; Rácz I; Derova J; Jonaitis L; Wehrum S; Nacak T; Greinwald R
    United European Gastroenterol J; 2020 Dec; 8(10):1186-1195. PubMed ID: 33028169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of ulcerative colitis following diversion colitis.
    Yaguchi K; Matsune Y; Kunisaki R; Araki K; Kimura H; Inayama Y; Kumagai J; Maeda S
    Clin J Gastroenterol; 2022 Dec; 15(6):1088-1093. PubMed ID: 36068373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
    Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema.
    Sugisaki K; Honma F; Iwadate H; Shio K; Shioya Y; Fukaya E; Sato K; Saito H; Sekine H; Kobayashi H; Orikasa H; Watanabe H; Sato Y
    Intern Med; 2004 Nov; 43(11):1046-50. PubMed ID: 15609700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment.
    Frieri G; Pimpo MT; Palumbo GC; Onori L; Viscido A; Latella G; Galletti B; Pantaleoni GC; Caprilli R
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1413-7. PubMed ID: 10571596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
    Schreiber S; Hanauer SB; Sandborn WJ; Barrett K
    J Crohns Colitis; 2020 Sep; 14(9):1274-1281. PubMed ID: 32179906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis.
    Wilding IR; Kenyon CJ; Chauhan S; Hooper G; Marshall S; McCracken JS; Staab HJ; Armbrecht J
    Aliment Pharmacol Ther; 1995 Apr; 9(2):161-6. PubMed ID: 7605856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.